Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response
This article was originally published in The Gray Sheet
Executive Summary
Circulating tumor cell chips show promise as monitors of cancer therapy response in a study led by the Massachusetts General Hospital Cancer Center published July 2 in the New England Journal of Medicine